Navigation Links
Infectious Diseases Institute Appoints Alex Coutinho, M.D as Executive Director
Date:11/29/2007

WASHINGTON, Nov. 29 /PRNewswire-USNewswire/ -- Today, the Infectious Diseases Institute (IDI) announced the appointment of Alex Coutinho, M.D., a world-renowned leader in HIV/AIDS prevention and treatment, as the new Executive Director of the IDI.

Prior to joining IDI, Dr. Coutinho spent six years leading The AIDS Support Organization (TASO) Uganda, the largest HIV/AIDS care and treatment organization in Africa. His impressive accomplishments at TASO include increasing the organization's annual funding from $3 million to $22 million and expanding care for HIV-positive clients from 20,000 to 80,000. Dr. Coutinho was recently featured in Vanity Fair's Africa Issue, where he was recognized for his remarkable work in the field of HIV/AIDS.

IDI was the inaugural project of the Academic Alliance Foundation (AAF), a non-profit organization whose mission is to overcome the burden of infectious disease in Africa by building healthcare capacity and by strengthening academic medical institutions. "We are thrilled to have Dr. Coutinho assume leadership of the IDI," said Hank McKinnell, Chairman of the Board of the AAF. "His experience and expertise will bring tremendous value to the organization and to millions of people, families, and children in sub-Sahara Africa. Alex is the right man for these difficult times."

Dr. Coutinho will lead the day-to-day activities at IDI, including overseeing the organization's programs, which are aimed at building capacity in Africa to care for AIDS patients and to prevent the further spread of HIV. The program areas include: prevention, care and treatment, training, research, and laboratory services.

"I am honored to join IDI and to continue to build upon the past success," said Dr. Alex Coutinho. "I believe firmly in the mission of IDI - to build capacity in Africa for the delivery of sustainable, high quality care and prevention of HIV/AIDS and related infectious diseases through training and research. As someone who has lost family members to the HIV/AIDS epidemic, I am well aware of the devastating effect this disease has had, and continues to have, on the people of Africa and around the world. I am excited to help shape and drive the important programs IDI has established."

Dr. Coutinho has been involved in the prevention and treatment of HIV/AIDS since 1982 when the first cases began to appear in Uganda. Early in his career he assisted in managing the initial AIDS cases at Nsambya Hospital in Kampala, and spent two years volunteering as part of a UNICEF/MOH initiative coordinating an intensive HIV education campaign for schools in Kampala and Masaka, Uganda. From 1989-2001, Dr. Coutinho worked in Swaziland pioneering HIV education and prevention programs at local and national levels.

Dr. Coutinho has been a member of the interim board of the Global Fund to Fight AIDS, TB and Malaria, representing TASO in the process of setting up the fund in 2001. He was also the vice-chair of the Global Fund Technical Review from 2002-2004 and has served as the Vice Chairperson of the International Board for the International Partnership for Microbicides (IPM) since 2005.

About the Infectious Diseases Institute

The inaugural program of the Academic Alliance Foundation, the Infectious Diseases Institute of Makerere University (IDI), is a regional centre of excellence for HIV/AIDS treatment, training and research in sub-Saharan Africa. At IDI doctors and other health workers from all over sub-Saharan Africa receive advanced training in HIV/AIDS care and antiretroviral therapy (ART); people living with HIV receive free clinical care including ART; and scientists conduct research to develop models for HIV/AIDS prevention and treatment on the African continent. The IDI was established by the Academic Alliance for AIDS Care and Prevention in Africa, a grouping of infectious disease experts from Uganda and North America, supported by Pfizer Inc and other partners. Since July 2005, the IDI has operated as an independent institute of Makerere University. For more information visit the IDI website: http://www.idi.ac.ug.

About the Academic Alliance Foundation

The Academic Alliance Foundation is a U.S. not-for-profit corporation whose mission is to overcome the burden of infectious diseases in sub-Saharan Africa by building healthcare capacity and strengthening academic medical institutions. AAF was born out of a unique partnership between senior North American academic physician-researchers in the field of infectious disease, their counterparts on the Faculty of Medicine at Uganda's famed Makerere University, and others motivated to find innovative solutions to combat infectious disease in sub-Saharan Africa and strengthen Africa for future generations. For more information visit the AAF website: http://www.academicalliancefoundation.org.


'/>"/>
SOURCE Academic Alliance Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
2. Infectious diseases experts applaud bill against bad bugs
3. MultiVu Video Feed: Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With "Silence the Sounds of Pertussis" Campaign
4. Einstein scientists treat cancer as an infectious disease -- with promising results
5. Northwestern exposing most deadly infectious diseases in 3-D
6. Southern Research Institute Names Vladimir Yamshchikov Director of Infectious Disease Research Department in Birmingham
7. Study shows suppressing herpes virus may reduce infectiousness of HIV
8. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
9. Radiologists encouraged to look beyond cancer for clinically unseen diseases
10. New viruses to treat bacterial diseases -- My enemies enemy is my friend
11. Elsevier announces new journal on inflammatory bowel diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: